Mirum Pharmaceuticals (MIRM) Interest Expenses (2020 - 2026)

Mirum Pharmaceuticals' Interest Expenses history runs 7 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• In Q1 2026, Interest Expenses rose 0.56% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $14.4 million (up 0.55% YoY), while the FY2025 annual figure was $14.4 million, up 0.55% from the prior year.
• Interest Expenses was $3.6 million for Q1 2026 at Mirum Pharmaceuticals, up from $3.6 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $4.4 million in Q4 2022 to a low of $3.6 million in Q4 2023.
• Historically, Interest Expenses has averaged $3.7 million across 5 years, with a median of $3.6 million in 2025.
• Biggest YoY gain for Interest Expenses was 15.75% in 2022; the steepest drop was 29.93% in 2022.
• A 5-year view of Interest Expenses shows it stood at $4.4 million in 2022, then slipped by 18.26% to $3.6 million in 2023, then advanced by 0.45% to $3.6 million in 2024, then grew by 0.53% to $3.6 million in 2025, then rose by 0.5% to $3.6 million in 2026.
• The last three Interest Expenses figures came in at $3.6 million (Q1 2026), $3.6 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.